Hypertension is a chronic disease characterized by persistent high arterial blood pressure and is the most important preventable factor for premature mortality in the world. Elevated blood pressure is a common cause of heart diseases such as ischemic heart disease, stroke, peripheral vascular disease, heart failure, aortic aneurysm, and extensive atherosclerosis. Hypertension is also a high-risk factor for cognitive impairment, dementia, and chronic kidney disease. There is no cure for hypertension in western medicine, and the disease is mainly treated by controlling blood pressure, alleviating secondary lesions in other organs, and reducing disability and mortality. Stabilizing the blood pressure with antihypertensive drugs is currently the most effective treatment. Antihypertensive drugs are easy to get and the resulting effect is long-lasting and stable. However, the long-term administration is required and most of them have adverse effects. Some patients with mild-to-moderate hypertension are unwilling to take antihypertensive drugs, and frail patients are deemed not suitable for long-term administration of these drugs. Instead of focusing on reducing the blood pressure only, the traditional Chinese medicine (TCM) emphasizes the individualized treatment based on syndrome differentiation to regulate the whole body, thereby reducing blood pressure, delaying complications, and promoting the recovery. With the gradual acceptance and acknowledgement of TCM worldwide, the potential advantages of acupuncture in improving hypertension have been increasingly recognized.
Since 2014, Chinese Acupuncture & Moxibustion, Acupuncture Research, China Journal of Chinese Materia Medica, Chinese Pharmacological Bulletin, Chinese Journal of Integrated Traditional and Western Medicine, Liaoning Journal of Traditional Chinese Medicine, The Chinese Journal of Clinical Pharmacology, Acta Pharmaceutica Sinica, World Chinese Medicine, and Chinese Archives of Traditional Chinese Medicine have joined the Journal Translation Project (JTP, http://jtp.cnki.net/bilingual). As of 2020, 2 564 articles from these journals have been included in JTP and published in both Chinese and English, which has enhanced the international influence of these journals. To further promote the international dissemination of TCM culture and the related journals, and enable more readers to learn about the research progress of hypertension treatment with TCM, China National Knowledge Infrastructure (CNKI) collaborates with the editorial boards of these journals to constitute a panel of experts and select 23 excellent articles concerning hypertension treatment with TCM, which have been compiled into the book Hypertension (TCM) (English edition) as part of China’s Medicine Progress Series (English edition). The articles included are recommended by the editorial boards of the journals in which they were originally published, and the content mainly covers the theoretical, mechanism, and clinical studies, fully demonstrating the unique therapies and good efficacy of TCM in treating hypertension, with scientific methodological support and objective conclusions. The original articles were published in Chinese, and this book is a compilation of English version of selected articles.
As the editor-in-chief, I believe that this book will provide useful experience and methods from the TCM filed in China for hypertension treatment worldwide, as well as the scientific, practical, and up-to-date literature for TCM and acupuncture practitioners worldwide, allowing the TCM journals and the healthcare concepts and methods advocated in TCM to be better understood and disseminated.
Editor-in-chief: LIU Baoyan收起